{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:16:09Z","timestamp":1789143369478,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117131","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:47:29Z","timestamp":1785527249000},"page":"117131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery and development of small-molecule inhibitors targeting cytotoxic T lymphocyte associated protein 4 to enhance cancer immunotherapy and reduce side effects"],"prefix":"10.1016","volume":"187","author":[{"given":"Chong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117131_bb0185","doi-asserted-by":"crossref","first-page":"1392499","DOI":"10.3389\/fimmu.2024.1392499","article-title":"The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117131_bb0045","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijrobp.2023.11.040","article-title":"Combining dual checkpoint immunotherapy with ablative radiation to all sites of oligometastatic non-small cell lung cancer: toxicity and efficacy results of a phase 1b trial","volume":"118","author":"Bassetti","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.intimp.2026.117131_bb0210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41422-019-0184-1","article-title":"Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.117131_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2026.100134","article-title":"Immunomodulatory and anti-cancer effects of phytochemicals: a comprehensive analysis","author":"Eltokhy","year":"2026","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2026.117131_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apha.14087","article-title":"The lipid droplet in cancer: from being a tumor-supporting hallmark to clinical therapy","volume":"240","author":"Cui","year":"2024","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117131_bb0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.intimp.2026.117131_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150750","article-title":"CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis","volume":"132","author":"Morgan","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2026.117131_bb0080","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.chmed.2025.10.003","article-title":"Advancement of Astragali Radix in anti-tumor: active components and combination therapy","volume":"18","author":"Jiang","year":"2026","journal-title":"Chinese Herbal Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117131_bb0165","article-title":"Virtual screening and molecular docking studies with organosulfur and flavonoid compounds of garlic targeting the estrogen receptor protein for the therapy of breast cancer","volume":"13","author":"Sarkar","year":"2023","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2026.117131_bb0025","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1159\/000520328","article-title":"G-8 geriatric screening tool independently predicts progression-free survival in older ovarian cancer patients irrespective of maximal surgical effort: results of a retrospective cohort study","volume":"68","author":"Anic","year":"2022","journal-title":"Gerontology"},{"issue":"4","key":"10.1016\/j.intimp.2026.117131_bb0145","article-title":"Pre-operative geriatric screening and assessment as predictors of postoperative complications in older adults with gynecologic cancer: a pilot cohort study on a neglected issue","volume":"14","author":"Puviani","year":"2023","journal-title":"J. Geriatric Oncol."},{"key":"10.1016\/j.intimp.2026.117131_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2026.117131_bb0200","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2026.117131_bb0040","first-page":"20","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J. Chemother."},{"issue":"24","key":"10.1016\/j.intimp.2026.117131_bb0065","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jnci\/djj505","article-title":"Cancer stem cells and radiotherapy: new insights into tumor radioresistance","volume":"98","author":"Diehn","year":"2006","journal-title":"In J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.intimp.2026.117131_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/1535-7163.MCT-13-0608","article-title":"Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer","volume":"13","author":"You","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2026.117131_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2026.102997","article-title":"Inequalities in survival among children with central nervous system cancers and neuroblastoma: a population-based study","volume":"101","author":"Afshar","year":"2026","journal-title":"Cancer Epidemiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117131_bb0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00432-022-03934-1","article-title":"The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study","volume":"149","author":"Anic","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117131_bb0170","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.intimp.2026.117131_bb0085","first-page":"687","article-title":"Pediatric neurological cancer incidence and trends in the United States, 2000\u20132018","volume":"33","author":"Kong","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.intimp.2026.117131_bb0005","series-title":"Chemogenomics: Methods and Applications","first-page":"249","article-title":"The flexible pocketome engine for structural chemogenomics","author":"Abagyan","year":"2009"},{"key":"10.1016\/j.intimp.2026.117131_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nsb0797-527","article-title":"Solution structure of human CTLA-4 and delineation of a CD80\/CD86 binding site conserved in CD28","volume":"4","author":"Metzler","year":"1997","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"May","key":"10.1016\/j.intimp.2026.117131_bb0050","article-title":"Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and na\u00efve CD4+ T cells in the immunosuppressive microenvironment of cervical cancer","volume":"163","author":"Chen","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117131_bb0105","doi-asserted-by":"crossref","first-page":"19730","DOI":"10.1038\/s41598-022-24192-8","article-title":"Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma","volume":"12","author":"Lisowski","year":"2022","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.intimp.2026.117131_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30153228","article-title":"Enhanced NiFe2O4 catalyst performance and stability in anion exchange membrane water electrolysis: influence of Iron content and membrane selection","volume":"30","author":"Ahmed","year":"2025","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.intimp.2026.117131_bb0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41422-018-0012-z","article-title":"Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice","volume":"28","author":"Du","year":"2018","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117131_bb0110","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.aninu.2021.09.003","article-title":"Pyridoxine regulates hair follicle development via the PI3K\/Akt, Wnt and notch signalling pathways in rex rabbits","volume":"7","author":"Liu","year":"2021","journal-title":"Anim. Nutr."},{"key":"10.1016\/j.intimp.2026.117131_bb0190","doi-asserted-by":"crossref","DOI":"10.2174\/0115680096372729250715050452","article-title":"Single-cell transcriptomics: technical advances, applications and challenges in cancer drug discovery","author":"Yang","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.intimp.2026.117131_bb0125","series-title":"Computational Approaches in Drug Discovery, Development and Systems Pharmacology","first-page":"139","article-title":"Chapter 4 - artificial intelligence (AI) and machine learning in the treatment of various diseases","author":"Mittal","year":"2023"},{"key":"10.1016\/j.intimp.2026.117131_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijcce.2025.08.002","article-title":"Integrating artificial intelligence and quantum computing: a systematic literature review of features and applications","volume":"7","author":"Pineda","year":"2026","journal-title":"Int. J. Cognitive Comput. Eng."},{"issue":"2","key":"10.1016\/j.intimp.2026.117131_bb0160","first-page":"1","article-title":"Transforming healthcare with state-of-the-art medical-LLMs: a comprehensive evaluation of current advances using benchmarking framework","volume":"86","author":"Saha","year":"2025","journal-title":"Comput. Mater. Continua"},{"issue":"5","key":"10.1016\/j.intimp.2026.117131_bb0090","article-title":"Machine-learning scoring functions for structure-based drug lead optimization","volume":"10","author":"Li","year":"2020","journal-title":"Wiley Interdiscip. Rev.: Comput. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117131_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2026.130932","article-title":"Flavonoids: novel topoisomerase inhibitors in cancer therapy","volume":"1870","author":"Mazire","year":"2026","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"5","key":"10.1016\/j.intimp.2026.117131_bb0150","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3324\/haematol.2021.278288","article-title":"Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients \u2013 a matched control multicenter cohort study","volume":"107","author":"Ram","year":"2022","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.intimp.2026.117131_bb0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/08927022.2022.2072840","article-title":"Virtual screening of potential inhibitor against breast cancer-causing estrogen receptor alpha (ER\u03b1): molecular docking and dynamic simulations","volume":"48","author":"Muhammad","year":"2022","journal-title":"Mol. Simul."},{"issue":"1","key":"10.1016\/j.intimp.2026.117131_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00432-025-06378-5","article-title":"Impact of preoperative geriatric screening and comorbidity assessment in patients with vulvar and vaginal cancer","volume":"152","author":"Linz","year":"2026","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117131_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf118","article-title":"The prognostic role of geriatric 8 in patients with cancer: a meta-analysis and systematic review","volume":"30","author":"Chen","year":"2025","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.intimp.2026.117131_bb0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/jnci\/djad200","article-title":"Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis","volume":"115","author":"Anwar","year":"2023","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2026.117131_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102380","article-title":"Disparities in survival improvement for US childhood and adolescent cancer between 1995 and 2019: an analysis of population-based data","volume":"85","author":"Wang","year":"2023","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117131_bb0030","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00432-022-04038-6","article-title":"Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study","volume":"149","author":"Anic","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600977X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600977X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:02:56Z","timestamp":1789142576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600977X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S156757692600977X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117131","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and development of small-molecule inhibitors targeting cytotoxic T lymphocyte associated protein 4 to enhance cancer immunotherapy and reduce side effects","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117131"}}